Is there a rationale for heparin use among severe COVID-19 patients?

Savioli, Felicio

Is there a rationale for heparin use among severe COVID-19 patients? / Há uma justificativa para o uso de heparina nos pacientes graves com COVID-19?

Savioli, Felicio.

Savioli, Felicio; University of California San Diego. San Diego. US

Einstein (Säo Paulo) ; 18: eED5758, 2020.

Article in English | LILACS | ID: biblio-1133777

Subject(s)

Humans; Pneumonia, Viral/drug therapy; Heparin/therapeutic use; Coronavirus Infections/drug therapy; Anticoagulants/therapeutic use; Cytokines/metabolism; Critical Illness; Sepsis/drug therapy; Venous Thrombosis/metabolism; Disseminated Intravascular Coagulation/drug therapy; Pandemics; COVID-19

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Pneumonia, Viral / Heparin / Coronavirus Infections / Anticoagulants Limits: Humans Language: English Journal: Einstein (Säo Paulo) Journal subject: Medicine Year: 2020 Type: Article Affiliation country: United States Institution/Affiliation country: University of California San Diego/US

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google